Igor Sekulić, Boris Džudović, Jovan Matijašević, Uroš Batranović, Sinisa Rusovic, Miodrag Mihajlovic, Uroš Miladinović, Nemanja Rančić, Bojana Subotić, Natasa Novičić, Srdjan Gavrilović, Jelena Boskovic-Sekulic, Slobodan Obradović,
Background: Systemic thrombolytic therapy is not recommended for patients with intermediate-risk pulmonary embolism (PE) because of major bleeding and intracranial bleeding overcomes the benefit of reperfusion.Patients and methods: A total of 342 PE patients with intermediate-risk PE from the multicenter Serbian PE registry were involved in the study. Of this group, 227 were not treated with reperfusion therapy (anticoagulation only), 91 were treated with conventional thrombolysis protocols at the ...
Tópico(s): Atrial Fibrillation Management and Outcomes
2019 - Taylor & Francis | Acta Cardiologica
Nina Djukanović, Zoran Todorović, Danijela Zamaklar-Trifunović, Dragana Protić, Boris Džudović, Miodrag Ostojić, Slobodan Obradović,
This study shows that the abrupt cessation of one-year clopidogrel treatment was not associated with thrombotic events in a prospective, multicentre study that enrolled 200 patients subjected to coronary stent implantation and treated with aspirin + clopidogrel 1 year after the stent placement. The aim of the study was to investigate the causes of a sustained increase of platelet aggregability, considering that the values of platelet aggregation stimulated with ADP + PGE1 (ADPHS values) significantly ...
Tópico(s): Coronary Interventions and Diagnostics
2015 - Wiley | Clinical and Experimental Pharmacology and Physiology